Potential Contribution of Preoperative Neoadjuvant Concurrent Chemoradiation Therapy on Margin-Negative Resection in Borderline Resectable Pancreatic Cancer

被引：0
|
作者：
Chang Moo Kang
Yong Eun Chung
Jeong Youp Park
Jin Sil Sung
Ho Kyoung Hwang
Hye Jin Choi
Hyunki Kim
Si Young Song
Woo Jung Lee
机构：
[1] Yonsei University College of Medicine,Division of Hepatobiliary and Pancreas, Department of Surgery
[2] Yonsei University College of Medicine,Division of Gastroenterology
[3] Yonsei University College of Medicine,Department of Internal Medicine
[4] Yonsei University College of Medicine,Department of Radiologic Oncology
[5] Yonsei University College of Medicine,Department of Radiology
[6] Yonsei University College of Medicine,Division of Medical Oncology
[7] Yonsei University College of Medicine,Department of Pathology
[8] Yonsei University Health System,Pancreaticobiliary Cancer Clinic, Institute of Gastroenterology
[9] Young Yonsei Panceatic Tumor Study Group,undefined
来源：
Journal of Gastrointestinal Surgery | 2012年 / 16卷
关键词：
Neoadjuvant; Chemoradiation; Pancreatic cancer; Borderline resectable;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：509 / 517
页数：8
相关论文
共 50 条
  • [31] DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer
    Shinichiro Hasegawa
    Hidenori Takahashi
    Hirofumi Akita
    Yosuke Mukai
    Manabu Mikamori
    Kei Asukai
    Daisaku Yamada
    Hiroshi Wada
    Yoshiaki Fujii
    Takahito Sugase
    Masaaki Yamamoto
    Tomohira Takeoka
    Naoki Shinno
    Hisashi Hara
    Takashi Kanemura
    Naotsugu Haraguchi
    Junichi Nishimura
    Chu Matsuda
    Masayoshi Yasui
    Takeshi Omori
    Hiroshi Miyata
    Masayuki Ohue
    Osamu Ishikawa
    Masato Sakon
    BMC Cancer, 23
  • [32] The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular Involvement
    Lee, Jin Ho
    Kang, Chang Moo
    Bang, Seung Min
    Choi, Jin Young
    Seong, Jin Sil
    Hwang, Ho Kyoung
    Choi, Sung Hoon
    Lee, Woo Jung
    MEDICINE, 2015, 94 (31)
  • [33] Neoadjuvant Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
    Kovtun, K.
    Moser, J. A.
    Callery, M.
    Kent, T.
    Tseng, J.
    Miksad, R.
    Bullock, A.
    Schlechter, B.
    Mahadevan, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E198 - E198
  • [34] Updates on the Use of Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
    Chandhok, Namrata Sonia
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2014, 15 (02): : 91 - 94
  • [35] Outcome Following Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer
    Stokes, J. B.
    Walters, D. M.
    Norris, N. J.
    Stelow, E. B.
    Rich, T. A.
    Weiss, G. R.
    De Lange, E. E.
    Adams, R. B.
    Bauer, T. W.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 80 - 80
  • [36] Adjuvant Therapy versus neoadjuvant Therapy for Borderline resectable Pancreatic Cancer
    Manekeller, Steffen
    ZENTRALBLATT FUR CHIRURGIE, 2018, 143 (05): : 457 - 457
  • [37] Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy
    Barugola, Giuliano
    Partelli, Stefano
    Crippa, Stefano
    Capelli, Paola
    D'Onofrio, Mirko
    Pederzoli, Paolo
    Falconi, Massimo
    AMERICAN JOURNAL OF SURGERY, 2012, 203 (02): : 132 - 139
  • [38] Neoadjuvant or Adjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer: Which Is Preferred?
    O'Reilly, Eileen M.
    Ferrone, Cristina
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (16) : 1757 - +
  • [39] CT in the prediction of margin-negative resection in pancreatic cancer following neoadjuvant treatment: a systematic review and meta-analysis
    Sohee Park
    Jong Keon Jang
    Jae Ho Byun
    Jin Hee Kim
    Seung Soo Lee
    Hyoung Jung Kim
    Seung Baek Hong
    Seong Ho Park
    European Radiology, 2021, 31 : 3383 - 3393
  • [40] RANDOMIZED MULTICENTER STUDY OF NEOADJUVANT CHEMORADIATION THERAPY (CRT) ALONE OR IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH RESECTABLE OR BORDERLINE RESECTABLE PANCREATIC CANCER
    Rahma, Osama
    Katz, Mathew
    Bauer, Todd
    Wolpin, Brian
    Stucky, Chee-Chee
    Bekaii-Saab, Tanios
    Elias, Rawad
    Dias-Costa, Andressa
    Nowak, Jonathan
    Patrick, Lenehan
    Petroni, Gina
    Dougan, Stephanie
    Slingluff, Craig
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A1010 - A1010
12345